SELB NASDAQ
Selecta Biosciences, Inc.
1W: -25.9%
1M: -36.5%
3M: -40.4%
1Y: -47.9%
3Y: -79.4%
5Y: -87.9%
$0.88
Last traded 2023-12-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$3M
-92.8% ▼
5Y CAGR: -30.0%
Gross Profit
$0
+0.0% ▲
Operating Income
$0
+0.0% ▲
Net Income
-$130M
-68.3% ▼
EPS (Diluted)
$-5.02
-904.0% ▼
EBITDA
$0
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $85M | $111M | $0 | $39M | $3M |
| YoY Growth | +412.6% | +30.2% | -100.0% | +0.0% | -92.8% |
| Cost of Revenue | $69M | $72M | $0 | $0 | $0 |
| Gross Profit | $16M | $38M | $0 | $0 | $0 |
| Gross Margin | 19.2% | 34.7% | — | 0.0% | 0.0% |
| R&D Expenses | $69M | $72M | $72M | $45M | $58M |
| SG&A Expenses | $21M | $24M | $41M | $30M | $31M |
| Operating Expenses | $90M | $96M | $112M | $83M | $146M |
| Operating Income | -$5M | $15M | -$86M | $0 | $0 |
| Operating Margin | -5.4% | 13.1% | — | 0.0% | 0.0% |
| Interest Expense | $3M | $3M | -$3M | $0 | $0 |
| Income Before Tax | -$10M | $35M | -$239M | -$77M | -$139M |
| Tax Expense | $16M | -$609K | -$19M | -$287K | $9M |
| Net Income | -$26M | $35M | -$220M | -$77M | -$130M |
| Net Margin | -30.2% | 31.9% | — | -199.0% | -4658.6% |
| EPS (Diluted) | $-0.22 | $0.24 | $-1.42 | $-0.50 | $-5.02 |
| EBITDA | -$7M | $16M | -$241M | $0 | $0 |
| Shares Outstanding | 114M | 146M | 155M | 155M | 26M |